NL-OMON29253RecruitingNot Applicable
A prospective cohort study on the effectiveness and cost-effectiveness of Primary Care Plus (PC+)
Maastricht Universitair Medisch Centrum (MUMC+)0 sites3,660 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 3,660
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Included in the study are all adult patients (≥18 years) registered with a GP in the region Maastricht-Heuvelland who are referred during the intervention period via the TIPP system or via the GPs service desk with non-acute, non-
- •complex health problems to the medical specialities which provide primary care plus consultations (internal medicine, neurology, orthopaedics, dermatology, ophthalmology, rheumatology, gynecology, urology, ENT and in time possibly other medical specialties) and patients who give informed consent.
Exclusion Criteria
- •Excluded from participation in this study are patients present in general practice with: 1)
- •acute health problems which require immediate referral to hospital care; 2) complex health
- •problems that require more sophisticated diagnostics or treatments not available in a PC+
- •setting; 3) complaints related to a prior diagnosis of diabetes mellitus, chronic obstructive
- •pulmonary disease and/or vascular risks, i.e. conditions for which bundled payment contracts
- •exist between regional health insurers and ZIO.
Investigators
Similar Trials
Completed
Not Applicable
Prospective cohort study to evaluate the effectiveness, safety and long prognosis of endoscopic submucosal dissection for colorectal tumorcolorectal tumorJPRN-UMIN000010155Japan Gastroenterological Endoscopy Society537
Completed
Not Applicable
Prospective observational study on the efficacy and safety of EPA in advanced gastric cancer patients treated by S-1+CDDP as first line.gastric cancerJPRN-UMIN000016226Kyushu medical center, medical oncology30
Not yet recruiting
Unknown
Study on the efficacy and safety of Hydra valveCTRI/2024/05/067666Sahajanand Medical Technologies Limited (SMT)
Active, not recruiting
Unknown
Study to Evaluate the Effectiveness and Safety of PravastatiEndocrine, nutritional and metabolic diseasesKCT0009248Daiichi-Sankyo Korea8,464
Not yet recruiting
Not Applicable
A prospective study to examine the effectiveness and safety of neuraminidase inhibitors in index cases with presumed pandemic influenza infectioPandemic influenzaInfection - Other infectious diseasesACTRN12608000176369ational Centre in HIV Epidemiology and Clinical Research (NCHECR)1,000